NZ730593A - Recombinase mutants - Google Patents

Recombinase mutants

Info

Publication number
NZ730593A
NZ730593A NZ730593A NZ73059315A NZ730593A NZ 730593 A NZ730593 A NZ 730593A NZ 730593 A NZ730593 A NZ 730593A NZ 73059315 A NZ73059315 A NZ 73059315A NZ 730593 A NZ730593 A NZ 730593A
Authority
NZ
New Zealand
Prior art keywords
recombinase
improved
uvsx
amplification
recombinase mutants
Prior art date
Application number
NZ730593A
Other languages
English (en)
Inventor
Erin Bomati
Matthew William Kellinger
Jonathan Mark Boutell
Original Assignee
Illumina Cambridge Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumina Cambridge Ltd filed Critical Illumina Cambridge Ltd
Publication of NZ730593A publication Critical patent/NZ730593A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
    • C12Y306/01—Hydrolases acting on acid anhydrides (3.6) in phosphorus-containing anhydrides (3.6.1)
    • C12Y306/01008—ATP diphosphatase (3.6.1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/50—Other enzymatic activities
    • C12Q2521/501—Ligase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ730593A 2014-09-29 2015-09-29 Recombinase mutants NZ730593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462057056P 2014-09-29 2014-09-29
PCT/US2015/053012 WO2016054088A1 (en) 2014-09-29 2015-09-29 Recombinase mutants

Publications (1)

Publication Number Publication Date
NZ730593A true NZ730593A (en) 2023-06-30

Family

ID=54293382

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ730593A NZ730593A (en) 2014-09-29 2015-09-29 Recombinase mutants

Country Status (18)

Country Link
US (2) US9982244B2 (enExample)
EP (1) EP3201222B1 (enExample)
JP (2) JP2017529093A (enExample)
KR (3) KR20170065028A (enExample)
CN (1) CN107208075B (enExample)
AU (1) AU2015323936B2 (enExample)
BR (1) BR112017006542B1 (enExample)
CA (1) CA2962941C (enExample)
DK (1) DK3201222T3 (enExample)
ES (1) ES2729302T3 (enExample)
IL (1) IL251422B (enExample)
MX (1) MX385063B (enExample)
MY (1) MY182395A (enExample)
NZ (1) NZ730593A (enExample)
RU (1) RU2721920C2 (enExample)
SG (1) SG11201702493WA (enExample)
WO (1) WO2016054088A1 (enExample)
ZA (1) ZA201702248B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017529093A (ja) * 2014-09-29 2017-10-05 イルミナ ケンブリッジ リミテッド リコンビナーゼ変異体
WO2017172699A1 (en) * 2016-03-28 2017-10-05 Illumina, Inc. Recombinase mutants
JP7048609B2 (ja) * 2016-12-09 2022-04-05 ボリアル ジェノミクス, インコーポレイテッド 連結型ライゲーション
GB201704754D0 (en) 2017-01-05 2017-05-10 Illumina Inc Kinetic exclusion amplification of nucleic acid libraries
CN108913700B (zh) * 2018-08-16 2021-04-09 深圳市艾伟迪生物科技有限公司 gp32单链结合蛋白的制备方法、表达基因、重组表达载体及应用
CN115975956A (zh) * 2022-02-23 2023-04-18 杨挥 一种重组酶突变体及包含该突变体的核酸等温扩增反应体系

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223414A (en) 1990-05-07 1993-06-29 Sri International Process for nucleic acid hybridization and amplification
US8030000B2 (en) 2002-02-21 2011-10-04 Alere San Diego, Inc. Recombinase polymerase amplification
DK1499738T3 (da) 2002-02-21 2008-11-17 Asm Scient Inc Recombinase-polymerease-amplifikation
US7399590B2 (en) 2002-02-21 2008-07-15 Asm Scientific, Inc. Recombinase polymerase amplification
US6897069B1 (en) 2004-06-08 2005-05-24 Ambion, Inc. System and method for electroporating a sample
EP2829615B1 (en) 2005-07-25 2018-05-09 Alere San Diego, Inc. Kit for multiplexing recombinase polymerase amplification
US7742463B2 (en) 2005-08-18 2010-06-22 Hong Kong Applied Science And Technology Research Institute Co., Ltd. Security gatekeeper for a packetized voice communication network
EP2029782B1 (en) * 2006-05-04 2014-11-26 Alere San Diego, Inc. Recombinase polymerase amplification
WO2010141940A1 (en) * 2009-06-05 2010-12-09 Alere San Diego, Inc. Recombinase polymerase amplification reagents and kits
CN103153960B (zh) 2010-09-21 2015-02-25 巴斯夫欧洲公司 制备取代的n-苯基羟胺的方法
EP3978620A1 (en) * 2011-04-07 2022-04-06 Abbott Diagnostics Scarborough, Inc. Monitoring recombinase polymerase amplification mixtures
US8895249B2 (en) 2012-06-15 2014-11-25 Illumina, Inc. Kinetic exclusion amplification of nucleic acid libraries
JP2017529093A (ja) * 2014-09-29 2017-10-05 イルミナ ケンブリッジ リミテッド リコンビナーゼ変異体

Also Published As

Publication number Publication date
AU2015323936A1 (en) 2017-04-20
SG11201702493WA (en) 2017-04-27
KR102126641B1 (ko) 2020-06-24
CA2962941C (en) 2022-06-14
KR20200026320A (ko) 2020-03-10
JP2019213545A (ja) 2019-12-19
IL251422A0 (en) 2017-05-29
BR112017006542B1 (pt) 2023-11-14
JP6879519B2 (ja) 2021-06-02
US10344269B2 (en) 2019-07-09
DK3201222T3 (da) 2019-06-24
JP2017529093A (ja) 2017-10-05
WO2016054088A1 (en) 2016-04-07
US20160090581A1 (en) 2016-03-31
CN107208075B (zh) 2021-08-24
US9982244B2 (en) 2018-05-29
IL251422B (en) 2020-10-29
EP3201222A1 (en) 2017-08-09
MY182395A (en) 2021-01-23
RU2017110582A3 (enExample) 2019-04-15
CN107208075A (zh) 2017-09-26
RU2721920C2 (ru) 2020-05-25
AU2015323936B2 (en) 2021-03-11
ZA201702248B (en) 2019-06-26
US20180258409A1 (en) 2018-09-13
MX2017004034A (es) 2017-11-17
KR20170065028A (ko) 2017-06-12
ES2729302T3 (es) 2019-10-31
BR112017006542A2 (pt) 2018-01-23
CA2962941A1 (en) 2016-04-07
MX385063B (es) 2025-03-14
EP3201222B1 (en) 2019-04-10
KR20190037364A (ko) 2019-04-05
RU2017110582A (ru) 2018-11-07

Similar Documents

Publication Publication Date Title
MX2021004479A (es) Agentes biologicos y su uso en plantas.
WO2016057961A8 (en) Compositions and methods for promoting homology directed repair
EP4219744A3 (en) Methods of preparing nucleic acids for sequencing
EP4464338A3 (en) Systems for improving crispr/cas-mediated genome-editing
WO2014144761A3 (en) Increasing specificity for rna-guided genome editing
WO2017064566A3 (en) Inducible modification of a cell genome
MX2024007130A (es) Vehiculo utilitario.
WO2016057951A3 (en) Crispr oligonucleotides and gene editing
WO2016196765A3 (en) Companion methods and kits for il-2-based therapies and mesenchymal stem cell-based therapies
TWD170128S (zh) 汽車輪圈(二)
TWD170127S (zh) 汽車輪圈(一)
WO2015134787A3 (en) Methods using randomer-containing synthetic molecules
GB2548740A (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
WO2015200902A8 (en) Endophytes, associated compositions, and methods of use thereof
WO2016094839A3 (en) Compositions and methods for performing methylation detection assays
EP3161127A4 (en) Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof
EP4286517A3 (en) Therapeutic uses of genome editing with crispr/cas systems
MY182395A (en) Recombinase mutants
WO2015149034A3 (en) Gene fusions and gene variants associated with cancer
HK1255446A1 (zh) 分子质量保证方法在测序中的应用
WO2016101960A3 (en) Yeast for preparing alcoholic beverages
AU2015243186A8 (en) Semisynthetic routes to organic compounds
WO2015112948A3 (en) Methods for determining a nucleotide sequence
WO2015171852A3 (en) Methods and compositions for non-cytotoxic stem cell transplantation
MX2022000516A (es) Metodos relacionados con celulas pluripotentes.

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE OWNER HAS BEEN CORRECTED TO 3560809, ILLUMINA CAMBRIDGE LIMITED, LITTLE CHESTERFORDNR SAFFRON WALDEN, CB10 1XL CB10 1XL, GB

Effective date: 20170602

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2025 BY PAVIS PAYMENTS GMBH

Effective date: 20240916

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 SEP 2026 BY PAVIS PAYMENT GMBH

Effective date: 20250917